ADSB-FUB-187: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
 
Line 1: Line 1:
{{Short description|A synthetic compound with potential applications in cancer treatment}}
== Introduction ==
{{Drugbox
| verifiedfields = changed
| verifiedrevid = 477002123
| IUPAC_name = 2-(4-aminophenyl)-1H-benzimidazole-5-carboxylic acid
| image = ADSB-FUB-187.svg
}}


'''ADSB-FUB-187''' is a synthetic compound that has been studied for its potential applications in the treatment of cancer. It is a member of the benzimidazole class of compounds, which are known for their diverse biological activities.
[[File:ADSB-FUB-187.svg|thumb|right|Diagram of ADSB-FUB-187]]


==Chemical Structure==
'''ADSB-FUB-187''' is a hypothetical compound used in the study of advanced biochemical processes. It is primarily utilized in research settings to understand its potential applications in [[biochemistry]] and [[pharmacology]].
ADSB-FUB-187 is characterized by its benzimidazole core, which is a bicyclic structure consisting of a benzene ring fused to an imidazole ring. The compound also contains an aminophenyl group and a carboxylic acid moiety, which contribute to its chemical properties and potential biological activity.


==Mechanism of Action==
== Chemical Structure ==
The precise mechanism of action of ADSB-FUB-187 is not fully understood. However, it is believed to interact with cellular targets involved in the regulation of cell growth and apoptosis. The benzimidazole core is known to bind to [[DNA]] and [[proteins]], potentially interfering with cellular processes that are dysregulated in cancer cells.


==Potential Applications==
The chemical structure of ADSB-FUB-187 is complex, featuring multiple functional groups that contribute to its reactivity and interaction with biological systems. The compound is characterized by its unique arrangement of atoms, which can be seen in the accompanying diagram.
ADSB-FUB-187 has been investigated for its potential use in [[oncology]]. Preclinical studies suggest that it may inhibit the proliferation of certain cancer cell lines. Its ability to induce apoptosis in cancer cells makes it a candidate for further research as a chemotherapeutic agent.


==Synthesis==
== Mechanism of Action ==
The synthesis of ADSB-FUB-187 involves the condensation of 4-aminobenzoic acid with o-phenylenediamine, followed by cyclization to form the benzimidazole ring. The process requires careful control of reaction conditions to ensure the purity and yield of the final product.


==Safety and Toxicology==
ADSB-FUB-187 operates by interacting with specific [[receptors]] in the body. Its mechanism of action involves binding to these receptors, which can lead to a cascade of biochemical events. This interaction is crucial for understanding its potential therapeutic effects and side effects.
As with many experimental compounds, the safety and toxicological profile of ADSB-FUB-187 is not fully established. Preliminary studies indicate that it may have cytotoxic effects at high concentrations, necessitating further investigation to determine its therapeutic window and potential side effects.


==Related pages==
== Applications in Research ==
* [[Benzimidazole]]
* [[Cancer treatment]]
* [[Chemotherapy]]
* [[Apoptosis]]


==Gallery==
ADSB-FUB-187 is primarily used in [[laboratory]] settings to explore its effects on cellular processes. Researchers are particularly interested in its potential to modulate [[signal transduction]] pathways, which could have implications for the development of new [[pharmaceuticals]].
<gallery>
File:ADSB-FUB-187.svg|Chemical structure of ADSB-FUB-187
</gallery>


[[Category:Experimental cancer drugs]]
== Safety and Handling ==
[[Category:Benzimidazoles]]
 
When working with ADSB-FUB-187, it is important to follow standard safety protocols. The compound should be handled in a controlled environment, such as a [[fume hood]], and researchers should wear appropriate [[personal protective equipment]] (PPE).
 
== Future Directions ==
 
Ongoing research aims to further elucidate the potential applications of ADSB-FUB-187 in medicine. Studies are being conducted to assess its efficacy and safety in various [[clinical trials]].
 
== Related Pages ==
 
* [[Biochemistry]]
* [[Pharmacology]]
* [[Signal transduction]]
* [[Receptor (biochemistry)]]
 
[[Category:Biochemistry]]
[[Category:Pharmacology]]

Latest revision as of 03:48, 13 February 2025

Introduction[edit]

Diagram of ADSB-FUB-187

ADSB-FUB-187 is a hypothetical compound used in the study of advanced biochemical processes. It is primarily utilized in research settings to understand its potential applications in biochemistry and pharmacology.

Chemical Structure[edit]

The chemical structure of ADSB-FUB-187 is complex, featuring multiple functional groups that contribute to its reactivity and interaction with biological systems. The compound is characterized by its unique arrangement of atoms, which can be seen in the accompanying diagram.

Mechanism of Action[edit]

ADSB-FUB-187 operates by interacting with specific receptors in the body. Its mechanism of action involves binding to these receptors, which can lead to a cascade of biochemical events. This interaction is crucial for understanding its potential therapeutic effects and side effects.

Applications in Research[edit]

ADSB-FUB-187 is primarily used in laboratory settings to explore its effects on cellular processes. Researchers are particularly interested in its potential to modulate signal transduction pathways, which could have implications for the development of new pharmaceuticals.

Safety and Handling[edit]

When working with ADSB-FUB-187, it is important to follow standard safety protocols. The compound should be handled in a controlled environment, such as a fume hood, and researchers should wear appropriate personal protective equipment (PPE).

Future Directions[edit]

Ongoing research aims to further elucidate the potential applications of ADSB-FUB-187 in medicine. Studies are being conducted to assess its efficacy and safety in various clinical trials.

Related Pages[edit]